CS253730B2 - Process for preparing new substituted amides - Google Patents
Process for preparing new substituted amides Download PDFInfo
- Publication number
- CS253730B2 CS253730B2 CS855344A CS534485A CS253730B2 CS 253730 B2 CS253730 B2 CS 253730B2 CS 855344 A CS855344 A CS 855344A CS 534485 A CS534485 A CS 534485A CS 253730 B2 CS253730 B2 CS 253730B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- het
- radical
- alkyl
- product
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8411442A FR2567887B1 (fr) | 1984-07-19 | 1984-07-19 | Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS253730B2 true CS253730B2 (en) | 1987-12-17 |
Family
ID=9306273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS855344A CS253730B2 (en) | 1984-07-19 | 1985-07-18 | Process for preparing new substituted amides |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4642308A (da) |
| EP (1) | EP0172083B1 (da) |
| JP (1) | JPS6163656A (da) |
| KR (1) | KR860001100A (da) |
| AT (1) | ATE33652T1 (da) |
| AU (1) | AU572672B2 (da) |
| CA (1) | CA1224787A (da) |
| CS (1) | CS253730B2 (da) |
| DD (1) | DD240011A5 (da) |
| DE (1) | DE3562250D1 (da) |
| DK (1) | DK327285A (da) |
| ES (1) | ES8604584A1 (da) |
| FI (1) | FI79313C (da) |
| FR (1) | FR2567887B1 (da) |
| GR (1) | GR851774B (da) |
| HU (1) | HU199802B (da) |
| IL (1) | IL75817A (da) |
| MA (1) | MA20487A1 (da) |
| NO (1) | NO161673C (da) |
| NZ (1) | NZ212764A (da) |
| OA (1) | OA08069A (da) |
| PH (1) | PH21301A (da) |
| PL (1) | PL145331B1 (da) |
| PT (1) | PT80840B (da) |
| SU (1) | SU1417797A3 (da) |
| YU (1) | YU118785A (da) |
| ZA (1) | ZA855409B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3662788D1 (en) * | 1985-07-11 | 1989-05-18 | Rhone Poulenc Sante | Substituted amides, their preparation and compositions containing them |
| FR2592882B2 (fr) * | 1986-01-16 | 1988-03-11 | Rhone Poulenc Sante | Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent |
| US4753941A (en) * | 1986-01-16 | 1988-06-28 | Rhone-Poulenc Sante | Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics |
| US5197518A (en) * | 1991-06-27 | 1993-03-30 | Double Containment Systems | Centering support assembly for double containment pipe systems |
| GB9711257D0 (en) * | 1997-05-30 | 1997-07-30 | Smithkline Beecham Plc | Novel compounds |
| EP1155017B1 (en) * | 1999-02-22 | 2003-01-15 | Shire Biochem Inc. | [1,8] naphthyridine derivatives having antiviral activity |
| JP4667384B2 (ja) * | 2003-10-07 | 2011-04-13 | レノビス， インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| US20080300243A1 (en) * | 2005-02-28 | 2008-12-04 | Kelly Michael G | Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| WO2013090725A1 (en) * | 2011-12-15 | 2013-06-20 | Philadelphia Health & Education Corporation | NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF |
| CN105646487B (zh) * | 2016-03-15 | 2017-12-05 | 红河学院 | 一类溴代1,8‑萘啶衍生物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB661515A (en) * | 1948-08-31 | 1951-11-21 | Cilag Ltd | Process for the production of naphthyridine derivatives |
| FR1006725A (fr) * | 1948-08-31 | 1952-04-28 | Cilag Spa | Nouveaux dérivés de la naphtyridine et procédé pour leur préparation |
| US3389142A (en) * | 1966-09-29 | 1968-06-18 | Bristol Myers Co | Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids |
| US3576809A (en) * | 1968-05-06 | 1971-04-27 | Miles Lab | 2-substituted derivatives of 6-methoxyquinoline |
| US3624097A (en) * | 1969-07-22 | 1971-11-30 | Warner Lambert Co | N-pyridine 5-aminooxazoles |
| US4466965A (en) * | 1982-07-26 | 1984-08-21 | American Hospital Supply Corporation | Phthalazine compounds, compositions and use |
-
1984
- 1984-07-19 FR FR8411442A patent/FR2567887B1/fr not_active Expired
-
1985
- 1985-06-28 CA CA000485859A patent/CA1224787A/fr not_active Expired
- 1985-07-15 IL IL75817A patent/IL75817A/xx unknown
- 1985-07-16 MA MA20712A patent/MA20487A1/fr unknown
- 1985-07-17 NZ NZ212764A patent/NZ212764A/en unknown
- 1985-07-17 DD DD85278694A patent/DD240011A5/de unknown
- 1985-07-17 GR GR851774A patent/GR851774B/el unknown
- 1985-07-17 PL PL1985254570A patent/PL145331B1/pl unknown
- 1985-07-17 AU AU45090/85A patent/AU572672B2/en not_active Ceased
- 1985-07-17 ZA ZA855409A patent/ZA855409B/xx unknown
- 1985-07-17 US US06/755,896 patent/US4642308A/en not_active Expired - Fee Related
- 1985-07-18 ES ES545336A patent/ES8604584A1/es not_active Expired
- 1985-07-18 KR KR1019850005134A patent/KR860001100A/ko not_active Application Discontinuation
- 1985-07-18 FI FI852821A patent/FI79313C/fi not_active IP Right Cessation
- 1985-07-18 DK DK327285A patent/DK327285A/da not_active Application Discontinuation
- 1985-07-18 CS CS855344A patent/CS253730B2/cs unknown
- 1985-07-18 DE DE8585401480T patent/DE3562250D1/de not_active Expired
- 1985-07-18 NO NO852877A patent/NO161673C/no unknown
- 1985-07-18 AT AT85401480T patent/ATE33652T1/de not_active IP Right Cessation
- 1985-07-18 HU HU852764A patent/HU199802B/hu not_active IP Right Cessation
- 1985-07-18 PH PH32541A patent/PH21301A/en unknown
- 1985-07-18 EP EP85401480A patent/EP0172083B1/fr not_active Expired
- 1985-07-18 SU SU853923698A patent/SU1417797A3/ru active
- 1985-07-19 OA OA58648A patent/OA08069A/xx unknown
- 1985-07-19 YU YU01187/85A patent/YU118785A/xx unknown
- 1985-07-19 PT PT80840A patent/PT80840B/pt not_active IP Right Cessation
- 1985-07-19 JP JP60158504A patent/JPS6163656A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2221414T3 (es) | Derivados de pirimidina. | |
| ES2605625T3 (es) | Moduladores de ciclopropilo del receptor P2Y12 | |
| TW201720817A (zh) | 趨化因子受體調節劑 | |
| EP2155712B1 (en) | 3-(imidazolyl)-pyrazolo[3,4-b]pyridines | |
| BG62933B1 (bg) | Нови химични съединения, притежаващи pde-iv(фосфодиестераза) инхибиторна активност | |
| BG66332B1 (bg) | Кристални форми на съединението триазоло(4,5-d)пиримидин | |
| CZ113297A3 (cs) | Derivát karboxylové kyseliny | |
| JPH03204880A (ja) | 縮合プリン誘導体 | |
| CS253730B2 (en) | Process for preparing new substituted amides | |
| CZ284896A3 (en) | Novel hydroxypyridinones, process of their preparation and pharmaceutical composition in which such hydroxypyridinones are comprised | |
| CA1054521A (en) | Biological materials | |
| US4847263A (en) | Imidazopyridine derivatives and compositions containing them | |
| JPH0755949B2 (ja) | 新規ピリド〔２，３−ｄ〕ピリミジン誘導体、その製造方法並びに該化合物を含有する医薬組成物 | |
| JP2004526712A (ja) | ６−フェニルベンゾナフチリジン | |
| JPS6363547B2 (da) | ||
| EP1057829B1 (en) | Novel compounds and pharmaceutical compositions containing the same | |
| AU774981B2 (en) | Thiazolopyrimidines useful as TNFalpha inhibitors | |
| EP0663210A2 (en) | Tumor necrosis factor production inhibitors | |
| WO1996026208A1 (fr) | Composes de purine et inhibiteurs de xanthine oxydase | |
| JPH07116188B2 (ja) | 新規ピリド〔４，３−ｄ〕ピリミジン誘導体、その製造方法並びに該化合物を含有する医薬組成物 | |
| JP2662765B2 (ja) | ピリド〔２，３−ｄ〕ピリミジン誘導体を含有する医薬組成物 | |
| JPH10245390A (ja) | 抗腫瘍性インドロピロロカルバゾール誘導体 | |
| JP4638736B2 (ja) | 新規のベンゾナフチリジン | |
| CN101218240A (zh) | 制备双环化合物的方法 | |
| DE102006014165A1 (de) | Neue Isooxazol-Derivate und deren Verwendungen |